This Short Communication by Jingwei Feng et al., University of Tokyo Graduate School of Medicine, Japan, researches the potential of micronized cellular adipose matrix — a bioactive injectable consisting of functional ECM and resident cells such as ASCs — to accelerate healing in ischemic diabetic ulcers.
Poor wound healing in diabetic patients affects millions of patients worldwide. There are many products for wound dressing available, but a transformative therapy is lacking. In a Regenerative Medicine Short Communication by Jingwei Feng et al., from the University of Tokyo Graduate School of Medicine (Japan) a bioactive injectable comprised of functional ECM and resident cells (including ASCs) was developed and investigated as a therapeutic for wound repair of diabetic skin ulcer.
Feng J, Doi K, Kuno S. Micronized cellular adipose matrix as a therapeutic injectable for diabetic ulcer. Regen. Med. 10(6), 699-708 (2015).